sorafenib has been researched along with Viremia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SC; Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Kuo, HT; Liang, PC; Lin, IH; Lin, ZY; Yeh, ML; Yu, ML | 1 |
1 other study(ies) available for sorafenib and Viremia
| Article | Year |
|---|---|
Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Hepacivirus; Humans; Life Expectancy; Liver; Liver Neoplasms; Male; Middle Aged; RNA, Viral; Sorafenib; Survival Analysis; Viremia | 2021 |